J.-L. Pirat, D. Virieux et al.
FULL PAPER
13C NMR (100.61 MHz, CDCl3, minor isomer): δ = 52.18 (s), 53.62
major isomer): δ = 18.99 (s, 78%) ppm. 31P NMR (81.01 MHz,
CD3OD, minor isomer): δ = 19.19 (s, 22 %) ppm. 1H NMR
(400.13 MHz, CD3OD, major isomer): δ = 4.72 (d, 2JP,H = 12.9 Hz,
2 H, PCH2), 5.30 (s, 1 H, CH), 7.71–7.80 (m, 19 H, CHAr) ppm.
2
3
1
(d, JP,C = 10.2 Hz), 73.58 (d, JP,C = 2.2 Hz), 124.14 (q, JF,C
271.5 Hz), 124.96 (q, JF,C = 3.7 Hz), 127.31 (s), 128.62 (d, JP,C
=
=
3
3
3
2
11.7 Hz), 128.74 (d, JP,C = 12.4 Hz), 129.77 (q, JF,C = 32.9 Hz),
130.07 (d, JP,C = 99.5 Hz), 130.10 (d, 1JP,C = 101.7 Hz), 131.94 (d,
1H NMR (400.13 MHz, CD3OD, minor isomer): δ = 4.87 (d, JP,H
1
2
2JP,C = 10.2 Hz), 131.95 (d, JP,C = 9.5 Hz), 132.43 (d, JP, C
=
= 13.1 Hz, 2 H, PCH2), 5.40 (s, 1 H, CH), 7.71–7.80 (m, 19 H,
2
4
4
2
3.7 Hz), 132.43 (d, JP,C = 2.9 Hz), 134.71 (d, JP,C = 8.8 Hz),
CHAr) ppm. 13C NMR (100.61 MHz, CD3OD, major isomer): δ =
1
3
1
3
137.58 (d, JP,C = 95.1 Hz), 145.11 (s), 170.70 (d, JP, C
=
31.66 (d, JP,C = 57.6 Hz, PCH2), 78.94 (d, JP,C = 9.2 Hz, CH),
116.95 (d, 3JP,C = 2.4 Hz, C), 119.13 (d, 1JP,C = 87.6 Hz, C), 126.13
(q, 3JF,C = 3.7 Hz, CH), 130.77 (s, CH), 131.58 (d, 3JP,C = 13.5 Hz,
7.3 Hz) ppm. IR (solid, KBr, major isomer): ν = 3222, 3075, 2954,
˜
2885, 2846, 1738, 1619, 1590, 1485, 1437, 1415, 1324, 1302, 1275,
1247, 1202, 1165, 1118, 1094, 1084, 1066, 1041, 1014, 968, 937,
846, 811, 780, 748, 728, 694, 647, 555, 520, 503 cm–1. MS (FAB+,
2
4
CH), 135.60 (d, JP,C = 10.4 Hz, CH), 136.86 (d, JP,C = 3.1 Hz,
CH), 142.09 (s, C) ppm. 13C NMR (100.61 MHz, CD3OD, minor
major isomer): m/z (%) = 497 (34) [M + Na]+, 475 (100) [M + isomer): δ = 32.53 (d, JP,C = 55.8 Hz, PCH2), 80.10 (d, JP,C
=
=
=
=
1
3
H]+, 457 (30) [M – H2O]+, 425 (10) [M – H2O – OCH3]+, 397 (8)
[M – H2O – CO2Me]+, 300 (15) [M – F3C – C6H4OH]+, 269 (30)
8.6 Hz, CH), 116.35 (d, JP,C = 2.4 Hz, C), 119.33 (d, JP, C
87.6 Hz, C), 126.60 (m, CH), 130.63 (s, CH), 131.58 (d, JP,C
3
1
3
[M – F3C – C6H4OH – OCH3]+, 201 (85) [Ph2PO]+. MS (FAB+, 13.5 Hz, CH), 135.55 (d, JP,C = 10.4 Hz, CH), 136.83 (d, JP,C
2
4
minor isomer): m/z (%) = 497 (15) [M + Na]+, 475 (100) [M +
H]+, 457 (24) [M – H2O]+, 425 (7) [M – H2O – OCH3]+, 397 (7)
[M – H2O – CO2Me]+, 300 (12) [M – F3C – C6H4OH]+, 269 (32)
[M – F3C – C6H4OH – OCH3]+, 201 (77) [Ph2PO]+. HRMS
(FAB+): calcd. for [C25H23O4F3P]+ 475.1286; found 475.1290.
3.1 Hz, CH), 142.39 (s, C) ppm. IR (solid, KBr): ν = 3147, 2847,
˜
2216, 1619, 1589, 1487, 1439, 1326, 1161, 1115, 1066, 996, 745,
719, 689, 516, 506, 490 cm–1. MS (FAB+): m/z (%) = 524 (100)
[M]+, 488 (15) [M – Cl]+, 262 (37) [Ph3P]+. HRMS (FAB+): calcd.
for [C29H23F3ClNOP]+ 524.1158; found 524.1124.
1-{[2-Chloro-2-cyano-3-(4Ј-nitrophenyl)-3-hydroxy]propyl}-
triphenylphosphonium Chloride (19): Compound 19 (1.01 g, 81%)
was obtained as a white solid. 31P NMR (81.01 MHz, CD3OD,
major isomer): δ = 19.00 (s, 70%) ppm. 31P NMR (81.01 MHz,
General Procedure for the Synthesis of Compounds 17–20: To a solu-
tion of aromatic aldehyde (2.50 mmol, 1.0 equiv.) were added tri-
phenylphosphine (656 mg, 2.50 mmol, 1.0 equiv.) in anhydrous
CH2Cl2 (10 mL) and zirconium tetrachloride (582 mg, 2.50 mmol,
1.0 equiv.) under nitrogen. Then, a solution of 2-chloroacrylonitrile
(200 μL, 2.50 mmol, 1 equiv.) in CH2Cl2 (4 mL) was added drop-
wise over 40 min. The reaction mixture was left at 18 °C for 21 h
and then hydrolyzed by the addition of water (15 mL). The water
phase was extracted with CH2Cl2 (3ϫ 15 mL), and the combined
organic layers were dried with Na2SO4 and evaporated under vac-
uum. The solid residue was washed with acetone (50 mL) and then
filtered.
CD3OD, minor isomer): δ = 19.18 (s, 30 %) ppm. 1H NMR
2
(250.13 MHz, CD3OD, major isomer): δ = 4.74 (d, JP, H
=
–13.1 Hz, 2 H, PCH2), 5.37 (s, 1 H, CH), 7.75–8.09 (m, 19 H,
1
CHAr) ppm. H NMR (250.13 MHz, CD3OD, minor isomer): δ =
4.74 (d, 2JP,H = –13.1 Hz, 2 H, PCH2), 5.46 (s, 1 H, CH), 7.75–8.09
(m, 19 H, CHAr) ppm. 13C NMR (100.61 MHz, CD3OD, major
1
2
isomer): δ = 32.35 (d, JP,C = 57.6 Hz, PCH2), 61.22 (d, JP,C
=
8.3 Hz, C), 79.37 (d, 3JP,C = 9.2 Hz, CH), 117.55 (d, 3JP,C = 3.7 Hz,
C), 119.79 (d, JP,C = 87.9 Hz, C), 124.92 (s, CH), 131.99 (s, CH),
132.31 (d, JP,C = 12.9 Hz, CH), 137.32 (d, JP,C = 10.7 Hz, CH),
137.61 (d, 4JP,C = 3.1 Hz, CH), 145.45 (d, 4JP,C = 0.9 Hz, C), 150.92
(s, C) ppm. 13C NMR (100.61 MHz, CD3OD, minor isomer): δ =
33.24 (d, 1JP,C = 56.7 Hz, PCH2), 60.15 (d, 2JP,C = 8.0 Hz, C), 80.49
1
3
2
1-[(2-Chloro-2-cyano-3-phenyl-3-hydroxy)propyl]triphenylphos-
phonium Chloride (17): Compound 17 (900 mg, 54%) was obtained
as a white solid. 31P NMR (81.01 MHz, CD3OD, major isomer): δ
= 20.51 (s, 71%) ppm. 31P NMR (81.01 MHz, CD3OD, minor iso-
mer): δ = 20.75 (s, 29%) ppm. 1H NMR (400.13 MHz, CD3OD,
3
3
(d, JP,C = 8.3 Hz, CH), 116.95 (d, JP,C = 3.4 Hz, C), 119.98 (d,
2
major isomer): δ = 4.57 and 4.66 (2 dd, 2J = 16.2 Hz, JP, H
=
1JP,C = 87.9 Hz, C), 125.95 (s, CH), 130.10 (s, CH), 132.75 (d, 3JP,C
12.9 Hz, 2JP,H = 12.6 Hz, 2 H, PCH2), 5.17 (s, 1 H, CH), 7.40–7.75
2
4
= 13.5 Hz, CH), 136.27 (d, JP,C = 10.4 Hz, CH), 137.57 (d, JP,C
= 3.4 Hz, CH), 145.76 (d, 4JP,C = 0.9 Hz, C), 150.88 (s, C) ppm. IR
(m, 20 H, CHAr) ppm. 1H NMR (400.13 MHz, CD3OD, minor iso-
2
mer): δ = 4.79 (d, JP,H = 12.6 Hz, 2 H, PCH2), 5.26 (s, H, CH),
(solid, KBr): ν = 3060, 2857, 2202, 1830, 1710, 1605, 1588, 1517,
˜
7.40–7.75 (m, 20 H, CHAr) ppm. 13C NMR (100.61 MHz, CD3OD,
1485, 1438, 1347, 1225, 1193, 1114, 1074, 995, 932, 896, 860, 840,
748, 689, 516, 507 cm–1. MS (FAB+): m/z (%) = 501 (100) [M]+,
465 (18) [M – Cl]+, 262 (100) [Ph3P]+. HRMS (FAB+): calcd. for
[C28H23O3N2PCl]+ 501.1135; found 501.1090.
major isomer): δ = 32.57 (d, 1JP,C = 57.0 Hz, PCH2), 61.65 (d, 2JP,C
3
3
= 8.0 Hz, C), 80.64 (d, JP,C = 8.0 Hz, CH), 117.82 (d, JP,C
=
3.7 Hz, C), 119.83 (d, 1JP,C = 88.2 Hz, C), 130.01 (s, 6 CH), 130.68
(s, CH), 131.46 (s, CH), 132.29 (d, 3JP,C = 13.5 Hz, CH), 136.28 (d,
1-{[2-Chloro-2-cyano-3-(4Ј-tolyl)-3-hydroxy]propyl}triphenyl-
phosphonium Chloride (20): Compound 20 (632 mg, 54%) was ob-
tained as a white solid. 31P NMR (81.01 MHz, CD3OD, major iso-
mer): δ = 20.15 (s, 69%) ppm. 31P NMR (81.01 MHz, CD3OD,
minor isomer): δ = 19.88 (s, 31%) ppm. 1H NMR (400.13 MHz,
CD3OD, major isomer): δ = 2.30 (s, 3 H, CH3), 5.06 (dd, 2J =
2JP,C = 10.4 Hz, CH), 137.55 (d, JP,C = 3.1 Hz, CH), 138.40 (s,
4
C) ppm. 13C NMR (100.61 MHz, CD3OD, minor isomer): δ =
33.24 (d, 1JP,C = 57.0 Hz, PCH2), 60.71 (d, 2JP,C = 8.0 Hz, C), 81.59
3
3
(d, JP,C = 9.2 Hz, CH), 117.42 (d, JP,C = 3.7 Hz, C), 120.08 (d,
1JP,C = 87.6 Hz, C), 130.00 (s, CH), 130.54 (s, CH), 131.44 (s, CH),
3
2
132.28 (d, JP,C = 12.9 Hz, CH), 136.24 (d, JP,C = 10.4 Hz, CH),
137.49 (d, 4JP,C = 3.1 Hz, CH), 138.70 (s, C) ppm. IR (solid, KBr):
2
2
–12.1 Hz, JP,H = –16.8 Hz, 1 H, PCH2), 5.36 (dd, J = –12.1 Hz,
2JP,H = –16.6 Hz, 1 H, PCH2), 5.63 (s, 1 H, CH), 7.10 (d, 3J =
ν = 3060, 2852, 2202, 1977, 1709, 1587, 1487, 1437, 1344, 1260,
˜
3
8.0 Hz, 2 H, CH), 7.45 (d, J = 8.0 Hz, 2 H, CH), 7.68–8.08 (2 m,
1109, 1059, 996, 746, 686, 606, 516, 506, 487 cm–1. MS (FAB+):
m/z (%) = 456 (55) [M]+, 420 (20) [M – Cl]+, 262 (30) [Ph3P]+.
HRMS (FAB+): calcd. for [C28H24ClNOP]+ 456.1284; found
456.1319.
15 H, CHAr) ppm. 1H NMR (400.13 MHz, CD3OD, minor iso-
mer): δ = 2.33 (s, 3 H, CH3), 4.89 (dd, 2J = –12.4 Hz, JP,H
=
2
2
2
–16.8 Hz, 1 H, PCH2), 5.69 (dd, J = –12.4 Hz, JP,H = –16.8 Hz,
1 H, PCH2), 5.43 (s, 1 H, CH), 7.10 (d, 3J = 8.0 Hz, 2 H, CH),
3
1-{[2-Chloro-2-cyano-3-(4Ј-trifluomethylphenyl)-3-hydroxy]propyl}-
triphenylphosphonium Chloride (18): Compound 18 (750 mg, 58%)
was obtained as a white solid. 31P NMR (81.01 MHz, CD3OD,
7.45 (d, J = 8.0 Hz, 2 H, CH) 7.68–8.08 (2m, 15 H, CHAr) ppm.
13C NMR (100.61 MHz, CD3OD, major isomer): δ = 21.29 (s,
1
2
CH3), 31.61 (d, JP,C = 57.5 Hz, PCH2), 60.93 (d, JP,C = 8.3 Hz,
794
www.eurjoc.org
© 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2014, 788–796